These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Avastin and diode laser: a combined modality in managing epistaxis in hereditary hemorrhagic telangiectasia. Marglani OA; Bawazeer NA; Abu Suliman OA Am J Otolaryngol; 2013; 34(5):603-5. PubMed ID: 23541684 [TBL] [Abstract][Full Text] [Related]
3. Influence of temporary nasal occlusion (tNO) on epistaxis frequency in patients with hereditary hemorrhagic telangiectasia (HHT). Wirsching KEC; Haubner F; Kühnel TS Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1891-1896. PubMed ID: 28070641 [TBL] [Abstract][Full Text] [Related]
4. A novel approach to manage recurrent epistaxis in outpatients with hereditary hemorrhagic telangiectasia. Cantone E; Marino A; Castagna G; Sicignano S; Rega F; Di Rubbo V; Iengo M Am J Emerg Med; 2014 Aug; 32(8):952.e1-2. PubMed ID: 24637140 [No Abstract] [Full Text] [Related]
5. A laser end piece for the treatment of Epistaxis using the Pulsed Dye Laser. Corlett JC; Shakespeare PG; Wright PA; Taylor PJ Clin Otolaryngol; 2008 Feb; 33(1):71-2. PubMed ID: 18302565 [No Abstract] [Full Text] [Related]
6. Combined therapy for epistaxis by hereditary hemorrhagic teleangiectasia: A 3-year follow up study on 45 patients. Papaspyrou G; Hecker D; Linxweiler M; Schick B; Al Kadah B J Craniomaxillofac Surg; 2017 Aug; 45(8):1179-1182. PubMed ID: 28615135 [TBL] [Abstract][Full Text] [Related]
8. A silicone nasal swab for the treatment of severe and recalcitrant epistaxis in hereditary hemorrhagic telangiectasia: an alternative to surgical nostril closure. Bruschini L; Seccia V; Dallan I Am J Otolaryngol; 2011; 32(4):301-3. PubMed ID: 20719406 [TBL] [Abstract][Full Text] [Related]
9. [Hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease) Management of epistaxis and oral hemorrhage by Nd-Yag laser]. Galletta A; Amato G Minerva Stomatol; 1998 Jun; 47(6):283-6. PubMed ID: 9738363 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of a topical sesame/rose geranium oil compound in patients with hereditary hemorrhagic telangiectasia associated epistaxis. Reh DD; Hur K; Merlo CA Laryngoscope; 2013 Apr; 123(4):820-2. PubMed ID: 23401038 [TBL] [Abstract][Full Text] [Related]
13. [Maxillary artery embolisation as a method of treatment of hemorrhages in Rendu-Osler-Weber Syndrome--our experience]. Barnaś S; Wilczyński K; Kiszka M; Gerber-Sekula A; Nowicki J Otolaryngol Pol; 2007; 61(5):884-6. PubMed ID: 18552041 [TBL] [Abstract][Full Text] [Related]
14. Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide. Franchini M; Frattini F; Crestani S; Bonfanti C J Thromb Thrombolysis; 2013 Oct; 36(3):355-7. PubMed ID: 23143669 [No Abstract] [Full Text] [Related]
15. Coblation for epistaxis management in patients with hereditary haemorrhagic telangiectasia: a multicentre case series. Joshi H; Woodworth BA; Carney AS J Laryngol Otol; 2011 Nov; 125(11):1176-80. PubMed ID: 21846415 [TBL] [Abstract][Full Text] [Related]
16. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia. Hitchings AE; Lennox PA; Lund VJ; Howard DJ Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079 [TBL] [Abstract][Full Text] [Related]